Perioperative NALIRIFOX (liposomal Irinotecan in Combination with Fluorouracil, Leucovorin, and Oxaliplatin) in Resectable Pancreatic Adenocarcinoma: Randomized Phase II Trial
Clinical trial NCT06816914 · RECRUITING
Trial details
- NCT number
- NCT06816914
- Sponsor
- Taichung Veterans General Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-05
- Primary completion
- 2027-02-05
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.